<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="review-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Cureus</journal-id><journal-id journal-id-type="iso-abbrev">Cureus</journal-id><journal-id journal-id-type="issn">2168-8184</journal-id><journal-title-group><journal-title>Cureus</journal-title></journal-title-group><issn pub-type="epub">2168-8184</issn><publisher><publisher-name>Cureus</publisher-name><publisher-loc>Palo Alto (CA)</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC12102583</article-id><article-id pub-id-type="doi">10.7759/cureus.82876</article-id><article-categories><subj-group subj-group-type="heading"><subject>Dentistry</subject></subj-group></article-categories><title-group><article-title>Antibiotic Paste as an Intracanal Medicament in Infected Primary Teeth: A Systematic Review</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Muacevic</surname><given-names>Alexander</given-names></name></contrib><contrib contrib-type="editor"><name><surname>Adler</surname><given-names>John R</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Barve</surname><given-names>Archita</given-names></name><xref rid="aff-1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Lakade</surname><given-names>Laxmi</given-names></name><xref rid="aff-1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Shah</surname><given-names>Preetam</given-names></name><xref rid="aff-1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Chaudhary</surname><given-names>Shweta</given-names></name><xref rid="aff-1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Jajoo</surname><given-names>Shweta</given-names></name><xref rid="aff-1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Joshi</surname><given-names>Gandhali</given-names></name><xref rid="aff-1" ref-type="aff">1</xref></contrib></contrib-group><aff id="aff-1">
<label>1</label>
Pediatric Dentistry, Bharati Vidyapeeth (Deemed to be University) Dental College and Hospital, Pune, IND </aff><author-notes><corresp id="cor1">
Archita Barve <email>archita.barve-dchpune@bvp.edu.in</email>
</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>23</day><month>4</month><year>2025</year></pub-date><pub-date date-type="collection" publication-format="electronic"><month>4</month><year>2025</year></pub-date><volume>17</volume><issue>4</issue><elocation-id>e82876</elocation-id><history><date date-type="received"><day>16</day><month>2</month><year>2025</year></date><date date-type="accepted"><day>23</day><month>4</month><year>2025</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2025, Barve et al.</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>Barve et al.</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 4.0., which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri xlink:href="https://www.cureus.com/articles/344173-antibiotic-paste-as-an-intracanal-medicament-in-infected-primary-teeth-a-systematic-review">This article is available from https://www.cureus.com/articles/344173-antibiotic-paste-as-an-intracanal-medicament-in-infected-primary-teeth-a-systematic-review</self-uri><abstract><p>Intracanal medicaments, such as antibiotic pastes, in infected primary teeth have been evaluated to treat persistent polymicrobial infections, especially with resistant species like <italic>Enterococcus faecalis</italic> and <italic>Candida albicans</italic>. Advanced formulations such as triple antibiotic paste (TAP), calcium hydroxide (Ca(OH)&#x02082;), clindamycin-modified TAP, and nanoparticle-based medicaments have been studied for microbial reduction and clinical outcomes. This systematic review included studies that had evaluated antibiotic pastes for intracanal use in primary teeth. A comprehensive electronic database search was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, and studies were evaluated for eligibility on a population, exposure, comparator, outcome, and study design (PECOS) framework. A comprehensive search was conducted across seven electronic databases that included PubMed, Scopus, Web of Science, ScienceDirect, Cochrane Library, Embase, and Google Scholar. Risk of bias was evaluated using RoB 2.0 and QUIN tools. Out of 381 studies, 11 studies met the inclusion criteria, which evaluated medicaments such as TAP, Ca(OH)&#x02082;, clindamycin-modified TAP, 3C paste, chitosan chlorhexidine (CS-CHX) nanoparticles, and herbal alternatives. Results showed that TAP and its modified forms showed better antimicrobial efficacy, with reductions of up to 99.95% for aerobes and 99.78% for anaerobes. New formulations like nanoparticle-based drugs and 3C paste are promising but need clinical validation. This study suggests the potential of tailored intracanal medicaments in pediatric endodontics.</p></abstract><kwd-group kwd-group-type="author"><kwd>antibiotic paste</kwd><kwd>c. albicans</kwd><kwd>e. faecalis</kwd><kwd>intracanal medicaments</kwd><kwd>primary teeth</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>Introduction and background</title><p>Infected primary teeth that are disinfected and treated endodontically can act as the best space maintainers in the oral cavity till the permanent teeth erupt. The developing permanent dentition is guided by the prior presence of the primary set, which affects mastication and speech development as well as facial aesthetics. If infections or other complications&#x000a0;lead to the loss of these teeth before they are replaced by permanent ones, the child might face problems such as malocclusion, speech impairment, and psychological issues&#x000a0;[<xref rid="REF1" ref-type="bibr">1</xref>,<xref rid="REF2" ref-type="bibr">2</xref>].</p><p>The anatomical and physiological characteristics of primary teeth, primarily their relatively thin enamel and dentin, large pulp chambers, and high permeability, make them more susceptible to infections&#x000a0;[<xref rid="REF3" ref-type="bibr">3</xref>]. These infections often have a polymicrobial etiology, but&#x000a0;anaerobic and facultative bacteria predominate. Such infections are treated both mechanically and chemically through debridement and disinfection, respectively, to remove pathogens that persist in inaccessible areas of the root canal system&#x000a0;[<xref rid="REF4" ref-type="bibr">4</xref>].</p><p>Intracanal medicaments are important in achieving microbial control inside the root canal system of primary teeth&#x000a0;[<xref rid="REF5" ref-type="bibr">5</xref>]. Among all the medicaments available, pastes with antibiotics have garnered much interest due to their wide-spectrum antimicrobial action. One of the most commonly used formulations is TAP, also known as triple antibiotic paste, a combination of ciprofloxacin, metronidazole, and minocycline&#x000a0;[<xref rid="REF6" ref-type="bibr">6</xref>]. Localized application of antibiotics has advantages, including a higher concentration at the site of infection, fewer systemic side effects, and a lower potential for systemic antibiotic resistance. However, the cytotoxic effects and potential tooth discoloration associated with minocycline have moved clinicians to use alternative formulations with comparative studies&#x000a0;[<xref rid="REF7" ref-type="bibr">7</xref>-<xref rid="REF10" ref-type="bibr">10</xref>].</p><p>Other intracanal medicaments, such as calcium hydroxide and chlorhexidine (CHX), have been in use for decades in pediatric endodontics because of their antimicrobial activity and the ability to create an unfavorable environment for bacterial survival&#x000a0;[<xref rid="REF8" ref-type="bibr">8</xref>]. Calcium hydroxide has a high pH and acts through the denaturation of bacterial proteins and neutralization of endotoxins. CHX, on the other hand, shows broad-spectrum antimicrobial activity with substantivity, meaning it remains effective over a considerable period of time&#x000a0;[<xref rid="REF11" ref-type="bibr">11</xref>]. The newer formulations that have come to light include chitosan-based medicaments and nanoparticles, among others; however, there is still ongoing active research into their long-term efficacy and safety&#x000a0;[<xref rid="REF12" ref-type="bibr">12</xref>].</p><p>Although promising, antibiotic pastes are not widely practiced, mainly owing to issues surrounding the risk of inducing antibiotic resistance, potential adverse effects, and variability in clinical outcomes described in the literature&#x000a0;[<xref rid="REF10" ref-type="bibr">10</xref>,<xref rid="REF13" ref-type="bibr">13</xref>]. The localized delivery of antibiotics might also lead to the development of resistance in the microflora of the root canal and oral cavity, which could impede long-term clinical success. To date, the literature presents a diverse range of studies on antibiotic pastes as applied to infected primary teeth; the usage of the latter necessitates the need for a systematic synthesis of this evidence in order to identify therapeutic potential, limitations, and the broader implications of antibiotic pastes in pediatric endodontics.</p></sec><sec sec-type="review"><title>Review</title><p>Materials and methodology</p><p>PECOS Protocol and PRISMA Guidelines</p><p>This systematic review was constructed in accordance with the PECOS framework to ensure structured and rigorous inclusion of relevant studies and adhered to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) reporting guidelines&#x000a0;[<xref rid="REF14" ref-type="bibr">14</xref>]&#x000a0;to ensure transparency and replicability. The PECOS elements were defined as follows:</p><p>P (population): infected primary teeth.</p><p>E (exposure): use of antibiotic paste as an intracanal medicament.</p><p>C (comparator): other intracanal medicaments such as calcium hydroxide, CHX, chitosan-CHX (CS-CHX) nanoparticles, and propolis.</p><p>O (outcomes): antibacterial efficacy and duration of intracanal medicament.</p><p>S (study design): randomized controlled trials (RCTs), clinical studies, cross-sectional studies, and in vitro studies.</p><p>Inclusion and&#x000a0;Exclusion Criteria</p><p>The inclusion and exclusion criteria developed for this review are presented in Table&#x000a0;<xref rid="TAB1" ref-type="table">1</xref>.</p><table-wrap position="float" id="TAB1"><label>Table 1</label><caption><title>Inclusion and exclusion criteria developed for this review</title></caption><table frame="hsides" rules="groups"><tbody><tr style="background-color:#ccc"><td rowspan="1" colspan="1">Criteria</td><td rowspan="1" colspan="1">Inclusion</td><td rowspan="1" colspan="1">Exclusion</td></tr><tr><td rowspan="1" colspan="1">Population</td><td rowspan="1" colspan="1">Infected primary teeth</td><td rowspan="1" colspan="1">Permanent teeth and young permanent teeth</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">Intervention</td><td rowspan="1" colspan="1">Antibiotic pastes (e.g., triple antibiotic paste, calcium hydroxide, and chlorhexidine)</td><td rowspan="1" colspan="1">Systemic antibiotic treatments</td></tr><tr><td rowspan="1" colspan="1">Comparator</td><td rowspan="1" colspan="1">Other intracanal medicaments (e.g., calcium hydroxide and propolis)</td><td rowspan="1" colspan="1">Studies with no comparator</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">Outcomes</td><td rowspan="1" colspan="1">Antibacterial efficacy and duration of medicament</td><td rowspan="1" colspan="1">Outcomes not related to antibacterial efficacy</td></tr><tr><td rowspan="1" colspan="1">Study design</td><td rowspan="1" colspan="1">RCTs, clinical studies, cross-sectional studies, and in vitro studies</td><td rowspan="1" colspan="1">Review articles, irrelevant articles, and case reports</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">Language</td><td rowspan="1" colspan="1">English</td><td rowspan="1" colspan="1">Non-English studies</td></tr><tr><td rowspan="1" colspan="1">Publication type</td><td rowspan="1" colspan="1">Full-text articles</td><td rowspan="1" colspan="1">Grey literature and unpublished studies</td></tr></tbody></table></table-wrap><p>Database Search Protocol</p><p>A comprehensive search was conducted across seven electronic databases that included PubMed, Scopus, Web of Science, ScienceDirect, Cochrane Library, Embase, and Google Scholar. Searches were carried out using Boolean operators and Medical Subject Headings in combination with free-text keywords (Table&#x000a0;<xref rid="TAB2" ref-type="table">2</xref>). In addition, filters for study type, language, and date of publication were applied.</p><table-wrap position="float" id="TAB2"><label>Table 2</label><caption><title>Search strings utilized for the review</title></caption><table frame="hsides" rules="groups"><tbody><tr style="background-color:#ccc"><td rowspan="1" colspan="1">Database</td><td rowspan="1" colspan="1">Search string</td></tr><tr><td rowspan="1" colspan="1">PubMed</td><td rowspan="1" colspan="1">("Antibiotic Paste" OR "Triple Antibiotic Paste") AND ("Primary Teeth" OR "Deciduous Teeth")</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">Scopus</td><td rowspan="1" colspan="1">TITLE-ABS-KEY("Antibiotic Paste") AND TITLE-ABS-KEY("Primary Teeth" OR "Infected Teeth")</td></tr><tr><td rowspan="1" colspan="1">Web of Science</td><td rowspan="1" colspan="1">TS=("Antibiotic Paste" OR "Intracanal Medicament") AND TS=("Deciduous Teeth" AND "Bacterial Pathogens")</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">ScienceDirect</td><td rowspan="1" colspan="1">("Antibiotic Medicaments" AND "Pediatric Dentistry") AND ("Infection Control")</td></tr><tr><td rowspan="1" colspan="1">Cochrane Library</td><td rowspan="1" colspan="1">MeSH descriptor: [Antibiotics] explode all trees AND MeSH descriptor: [Primary Teeth] explode all trees</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">Embase</td><td rowspan="1" colspan="1">("Antibiotic Intracanal Paste" OR "Triple Antibiotic Paste") AND ("Infected Deciduous Teeth")</td></tr><tr><td rowspan="1" colspan="1">Google Scholar</td><td rowspan="1" colspan="1">"Antibiotic Paste for Intracanal Use" AND "Primary Teeth Infection"</td></tr></tbody></table></table-wrap><p>Data Extraction Protocol</p><p>A standardized data extraction form was used by two independent reviewers to extract the data. The items involved included the title of study, authors, year of publication, study design, population characteristics, details of the intervention, comparator details, outcomes assessed, and key findings. Any disagreements were resolved by consulting a third reviewer. The corresponding authors were contacted for clarification on any necessary issues.</p><p>Bias Assessment Protocol</p><p>In the observational studies, the ROBINS-I instrument&#x000a0;[<xref rid="REF14" ref-type="bibr">14</xref>]&#x000a0;assessed confounding bias, selection bias, and measurement bias within seven domains. For RCTs, Cochrane&#x02019;s RoB 2.0 tool&#x000a0;[<xref rid="REF15" ref-type="bibr">15</xref>]&#x000a0;was used to check on random sequence generation, allocation concealment, blinding, incomplete outcome data, and selective reporting. For the in vitro studies, the QUIN tool&#x000a0;[<xref rid="REF16" ref-type="bibr">16</xref>]&#x000a0;was utilized.&#x000a0;</p><p>Results</p><p>Initially, a total of 381 records were identified by database searches, and no records were identified by registers. Forty-six duplicates were removed from the retrieved 335 records; these then advanced into the screening stage. No more records were excluded during this screening process. The reports of 37 were unavailable to retrieve. A total of 298 records went through eligibility assessment, and the studies that did not meet the inclusion criteria included those not using the PECOS protocol (n = 68), conducted in other languages (n = 48), case reports (n = 76), literature reviews (n = 55), and theses (n = 40). Based on the results of these assessments, 11 studies&#x000a0;were included in the review, with no other newly identified studies (Figure <xref rid="FIG1" ref-type="fig">1</xref>).&#x000a0;</p><fig position="anchor" fig-type="figure" id="FIG1"><label>Figure 1</label><caption><title>PRISMA flow diagram for systematic review</title><p>PRISMA,&#x000a0;Preferred Reporting Items for Systematic Reviews and Meta-Analyses</p></caption><graphic xlink:href="cureus-0017-00000082876-i01" position="float"/></fig><p>Demographic Characteristics</p><p>The studies were geographically diversified (Table&#x000a0;<xref rid="TAB3" ref-type="table">3</xref>), conducted in countries like India&#x000a0;[<xref rid="REF17" ref-type="bibr">17</xref>-<xref rid="REF19" ref-type="bibr">19</xref>], Iran&#x000a0;[<xref rid="REF20" ref-type="bibr">20</xref>,<xref rid="REF21" ref-type="bibr">21</xref>], Turkey&#x000a0;[<xref rid="REF22" ref-type="bibr">22</xref>], and Egypt. This reflects global interest and variability in clinical and laboratory settings. The publication years are between 2010 and 2024. This implies a changing trend as well as a consistent study regarding intracanal medicaments during the last 10 years&#x000a0;[<xref rid="REF17" ref-type="bibr">17</xref>-<xref rid="REF27" ref-type="bibr">27</xref>]. The study designs include RCTs, pilot studies, and in vitro experiments, and this balance is represented between the clinically relevant and controlled experimental methodologies. This is all done in an attempt to identify the best intervention&#x000a0;[<xref rid="REF17" ref-type="bibr">17</xref>-<xref rid="REF27" ref-type="bibr">27</xref>].</p><table-wrap position="float" id="TAB3"><label>Table 3</label><caption><title>Demographic characteristics of the included studies</title></caption><table frame="hsides" rules="groups"><tbody><tr style="background-color:#ccc"><td rowspan="1" colspan="1">Author name</td><td rowspan="1" colspan="1">Year</td><td rowspan="1" colspan="1">Location</td><td rowspan="1" colspan="1">Study design</td><td rowspan="1" colspan="1">Sample size</td><td rowspan="1" colspan="1">Follow-up period</td></tr><tr><td rowspan="1" colspan="1">Ahirwar et al. [<xref rid="REF17" ref-type="bibr">17</xref>]</td><td rowspan="1" colspan="1">2018</td><td rowspan="1" colspan="1">India</td><td rowspan="1" colspan="1">Randomized control trial</td><td rowspan="1" colspan="1">40</td><td rowspan="1" colspan="1">3 days</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">Chandra and Thosar [<xref rid="REF18" ref-type="bibr">18</xref>]</td><td rowspan="1" colspan="1">2024</td><td rowspan="1" colspan="1">Wardha, India</td><td rowspan="1" colspan="1">In vitro study</td><td rowspan="1" colspan="1">Not applicable</td><td rowspan="1" colspan="1">Not applicable</td></tr><tr><td rowspan="1" colspan="1">Dutta et al. [<xref rid="REF19" ref-type="bibr">19</xref>]</td><td rowspan="1" colspan="1">2017</td><td rowspan="1" colspan="1">Bhubaneswar, India</td><td rowspan="1" colspan="1">In vivo study</td><td rowspan="1" colspan="1">48</td><td rowspan="1" colspan="1">7 days</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">Ghahramani et al. [<xref rid="REF20" ref-type="bibr">20</xref>]</td><td rowspan="1" colspan="1">2020</td><td rowspan="1" colspan="1">Iran</td><td rowspan="1" colspan="1">Randomized control trial</td><td rowspan="1" colspan="1">39</td><td rowspan="1" colspan="1">1 week</td></tr><tr><td rowspan="1" colspan="1">Gholami et al. [<xref rid="REF21" ref-type="bibr">21</xref>]</td><td rowspan="1" colspan="1">2023</td><td rowspan="1" colspan="1">Shiraz, Iran</td><td rowspan="1" colspan="1">Randomized control trial</td><td rowspan="1" colspan="1">39</td><td rowspan="1" colspan="1">7 days</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">Karg&#x000fc;l et al. [<xref rid="REF22" ref-type="bibr">22</xref>]</td><td rowspan="1" colspan="1">2010</td><td rowspan="1" colspan="1">Turkey</td><td rowspan="1" colspan="1">Pilot study</td><td rowspan="1" colspan="1">57</td><td rowspan="1" colspan="1">1-4 years</td></tr><tr><td rowspan="1" colspan="1">Paikkatt et al. [<xref rid="REF23" ref-type="bibr">23</xref>]</td><td rowspan="1" colspan="1">2018</td><td rowspan="1" colspan="1">India</td><td rowspan="1" colspan="1">Randomized control trial</td><td rowspan="1" colspan="1">34</td><td rowspan="1" colspan="1">Not applicable</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">Qamar et al. [<xref rid="REF24" ref-type="bibr">24</xref>]</td><td rowspan="1" colspan="1">2023</td><td rowspan="1" colspan="1">Hazaribagh, India</td><td rowspan="1" colspan="1">Randomized control trial</td><td rowspan="1" colspan="1">60</td><td rowspan="1" colspan="1">7 days</td></tr><tr><td rowspan="1" colspan="1">Reddy et al. [<xref rid="REF25" ref-type="bibr">25</xref>]</td><td rowspan="1" colspan="1">2017</td><td rowspan="1" colspan="1">India</td><td rowspan="1" colspan="1">In vivo study</td><td rowspan="1" colspan="1">55</td><td rowspan="1" colspan="1">1 year</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">Verma et al. [<xref rid="REF26" ref-type="bibr">26</xref>]</td><td rowspan="1" colspan="1">2022</td><td rowspan="1" colspan="1">Gurugram, India</td><td rowspan="1" colspan="1">Randomized control trial</td><td rowspan="1" colspan="1">60</td><td rowspan="1" colspan="1">12 months</td></tr><tr><td rowspan="1" colspan="1">Wassel et al. [<xref rid="REF27" ref-type="bibr">27</xref>]</td><td rowspan="1" colspan="1">2023</td><td rowspan="1" colspan="1">Egypt</td><td rowspan="1" colspan="1">In vitro study</td><td rowspan="1" colspan="1">63</td><td rowspan="1" colspan="1">3 and 7 days</td></tr></tbody></table></table-wrap><p>The least number of patients was 34&#x000a0;[<xref rid="REF23" ref-type="bibr">23</xref>]. The highest was 63 for in vitro. This period after the treatment varied largely, which can be as short as three days in the studies of herbs&#x000a0;[<xref rid="REF17" ref-type="bibr">17</xref>]&#x000a0;to as long as 12 months in investigations into modified TAPs&#x000a0;[<xref rid="REF26" ref-type="bibr">26</xref>]&#x000a0;for both early and late effects of treatment to be assessed.</p><p>Clinical and Radiographic Findings</p><p>Within clinical results, the microbial inhibition was observed as being consistent between all treatments with TAP, and its modified versions were sometimes significantly more active than comparatives. The combination of TAP with CHX was also highly effective, with enhanced killing capacity of <italic>Enterococcus faecalis</italic> against standalone TAP or calcium hydroxide&#x000a0;[<xref rid="REF20" ref-type="bibr">20</xref>,<xref rid="REF23" ref-type="bibr">23</xref>]. The highest antibacterial activity was observed with nano-formulations such as CS-CHX nanoparticles, and residual effects were reported for a longer duration even after medicament removal&#x000a0;[<xref rid="REF27" ref-type="bibr">27</xref>].</p><p>Significant bacterial reduction was observed for novel 3C paste and herbal alternatives, like <italic>Ocimum sanctum</italic>, compared to TAP formulations, in particular against more resistant organisms like <italic>E. faecalis</italic>&#x000a0;[<xref rid="REF17" ref-type="bibr">17</xref>]. One documented study reported as much as a 99.95% reduction of aerobes and a 99.78% reduction of anaerobes with TAP,&#x000a0;pointing out strong antimicrobial activity&#x000a0;[<xref rid="REF21" ref-type="bibr">21</xref>]. Radiographic outcomes were rarely used for evaluation, but the data that is available for Pulpotec indicated better than clindamycin-modified TAP, mainly concerning furcation radiolucency and results for root resorption&#x000a0;[<xref rid="REF26" ref-type="bibr">26</xref>] (Table <xref rid="TAB4" ref-type="table">4</xref>).</p><table-wrap position="float" id="TAB4"><label>Table 4</label><caption><title>Technical characteristics of the included studies</title><p>TAP, triple antibiotic paste; CHX, chlorhexidine; CH, calcium hydroxide; DAP, double antibiotic paste; CS-CHX NPs, chitosan chlorhexidine nanoparticles</p></caption><table frame="hsides" rules="groups"><tbody><tr style="background-color:#ccc"><td rowspan="1" colspan="1">Author name</td><td rowspan="1" colspan="1">Types of intracanal medicament</td><td rowspan="1" colspan="1">Bacterial species targeted</td><td rowspan="1" colspan="1">Antibiotic composition and concentration</td><td rowspan="1" colspan="1">Duration of intracanal application</td><td rowspan="1" colspan="1">Clinical outcomes</td><td rowspan="1" colspan="1">Radiographic outcomes</td><td rowspan="1" colspan="1">Conclusion</td></tr><tr><td rowspan="1" colspan="1">Ahirwar et al. [<xref rid="REF17" ref-type="bibr">17</xref>]</td><td rowspan="1" colspan="1">TAP and <italic>Ocimum sanctum</italic>
</td><td rowspan="1" colspan="1">Aerobic and anaerobic</td><td rowspan="1" colspan="1">Essential oil</td><td rowspan="1" colspan="1">3 days</td><td rowspan="1" colspan="1">TAP is better than <italic>Ocimum sanctum</italic>
</td><td rowspan="1" colspan="1">Not applicable</td><td rowspan="1" colspan="1">Potential herbal alternative</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">Chandra and Thosar [<xref rid="REF18" ref-type="bibr">18</xref>]</td><td rowspan="1" colspan="1">3C antibiotic paste vs. TAP</td><td rowspan="1" colspan="1">
<italic>E. faecalis</italic>&#x000a0;and&#x000a0;<italic>C. albicans</italic>
</td><td rowspan="1" colspan="1">Ciprofloxacin, clindamycin, and cefaclor (1:1:1)</td><td rowspan="1" colspan="1">Not applicable</td><td rowspan="1" colspan="1">Significant bacterial reduction (zone of inhibition measured)</td><td rowspan="1" colspan="1">Not applicable</td><td rowspan="1" colspan="1">3C paste showed higher efficacy than TAP</td></tr><tr><td rowspan="1" colspan="1">Dutta et al. [<xref rid="REF19" ref-type="bibr">19</xref>]</td><td rowspan="1" colspan="1">Calcium hydroxide, TAP, and TAP + CHX</td><td rowspan="1" colspan="1">E. faecalis</td><td rowspan="1" colspan="1">Ciprofloxacin, metronidazole, and minocycline</td><td rowspan="1" colspan="1">1 week</td><td rowspan="1" colspan="1">Significant bacterial reduction</td><td rowspan="1" colspan="1">Not assessed</td><td rowspan="1" colspan="1">TAP + CHX showed superior efficacy</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">Ghahramani et al. [<xref rid="REF20" ref-type="bibr">20</xref>]</td><td rowspan="1" colspan="1">TAP and Ca(OH)<sub>2</sub>
</td><td rowspan="1" colspan="1">E. faecalis</td><td rowspan="1" colspan="1">TAP mix</td><td rowspan="1" colspan="1">7 days</td><td rowspan="1" colspan="1">Significant reduction</td><td rowspan="1" colspan="1">Not applicable</td><td rowspan="1" colspan="1">Effective for resistant bacteria</td></tr><tr><td rowspan="1" colspan="1">Gholami et al. [<xref rid="REF21" ref-type="bibr">21</xref>]</td><td rowspan="1" colspan="1">TAP vs. Nano-CH</td><td rowspan="1" colspan="1">Aerobic and anaerobic</td><td rowspan="1" colspan="1">Ciprofloxacin, metronidazole, and minocycline (20 mg/mL each)</td><td rowspan="1" colspan="1">7 days</td><td rowspan="1" colspan="1">99.95% aerobic and 99.78% anaerobic reduction (TAP)</td><td rowspan="1" colspan="1">Not assessed</td><td rowspan="1" colspan="1">TAP demonstrated higher efficacy than Nano-CH</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">Karg&#x000fc;l et al. [<xref rid="REF22" ref-type="bibr">22</xref>]</td><td rowspan="1" colspan="1">Single group: metronidazole</td><td rowspan="1" colspan="1">Anaerobic bacteria</td><td rowspan="1" colspan="1">Metronidazole 0.1 mL</td><td rowspan="1" colspan="1">1 week</td><td rowspan="1" colspan="1">75% clinical success</td><td rowspan="1" colspan="1">Normal root resorption</td><td rowspan="1" colspan="1">Successful for primary dentition</td></tr><tr><td rowspan="1" colspan="1">Paikkatt et al. [<xref rid="REF23" ref-type="bibr">23</xref>]</td><td rowspan="1" colspan="1">Ca(OH)<sub>2</sub>, CHX, and metronidazole</td><td rowspan="1" colspan="1">Aerobic and facultative anaerobic</td><td rowspan="1" colspan="1">1% gel formulations</td><td rowspan="1" colspan="1">Not applicable</td><td rowspan="1" colspan="1">Ineffective in complete elimination</td><td rowspan="1" colspan="1">Not applicable</td><td rowspan="1" colspan="1">Not effective in complete elimination</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">Qamar et al. [<xref rid="REF24" ref-type="bibr">24</xref>]</td><td rowspan="1" colspan="1">Ca(OH)<sub>2</sub> vs. TAP vs. TAP + CHX</td><td rowspan="1" colspan="1">E. faecalis</td><td rowspan="1" colspan="1">Ciprofloxacin, metronidazole, and minocycline (1:1:1)</td><td rowspan="1" colspan="1">7 days</td><td rowspan="1" colspan="1">Significant bacterial reduction</td><td rowspan="1" colspan="1">Not assessed</td><td rowspan="1" colspan="1">TAP + CHX showed superior efficacy</td></tr><tr><td rowspan="1" colspan="1">Reddy et al. [<xref rid="REF25" ref-type="bibr">25</xref>]</td><td rowspan="1" colspan="1">TAP and conventional pulpectomy</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">3MIX-MP</td><td rowspan="1" colspan="1">2 weeks</td><td rowspan="1" colspan="1">Excellent success rates</td><td rowspan="1" colspan="1">Statistically significant improvement</td><td rowspan="1" colspan="1">High success with TAP</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">Verma et al. [<xref rid="REF26" ref-type="bibr">26</xref>]</td><td rowspan="1" colspan="1">Pulpotec vs. ClinM-TAP</td><td rowspan="1" colspan="1">Poly-microbial</td><td rowspan="1" colspan="1">Ciprofloxacin, metronidazole, and Clindamycin (43%, 43%, and 14%, respectively)</td><td rowspan="1" colspan="1">1 week</td><td rowspan="1" colspan="1">88% success (Pulpotec) and 50% success (ClinM-TAP)</td><td rowspan="1" colspan="1">60% success (Pulpotec) and 27% success (ClinM-TAP)</td><td rowspan="1" colspan="1">Pulpotec showed superior results</td></tr><tr><td rowspan="1" colspan="1">Wassel et al. [<xref rid="REF27" ref-type="bibr">27</xref>]</td><td rowspan="1" colspan="1">DAP, CHX, and CS-CHX NPs</td><td rowspan="1" colspan="1">
<italic>E. faecalis</italic> and <italic>C. albicans</italic>
</td><td rowspan="1" colspan="1">Various</td><td rowspan="1" colspan="1">3 and 7 days</td><td rowspan="1" colspan="1">CS-CHX NPs are highly effective</td><td rowspan="1" colspan="1">Higher residual effect</td><td rowspan="1" colspan="1">CS-CHX NPs recommended</td></tr></tbody></table></table-wrap><p>Bias Levels Assessed</p><p>Domains D1 and D5 showed notable heterogeneity under the RoB 2.0 tool (Figure&#x000a0;<xref rid="FIG2" ref-type="fig">2</xref>). &#x0201c;High&#x0201d; risk for study design is reported for the studies by Ahirwar et al.&#x000a0;[<xref rid="REF17" ref-type="bibr">17</xref>]&#x000a0;and Dutta et al.&#x000a0;[<xref rid="REF19" ref-type="bibr">19</xref>]. In the case of study design, the studies by Karg&#x000fc;l et al.&#x000a0;[<xref rid="REF22" ref-type="bibr">22</xref>]&#x000a0;and Verma et al.&#x000a0;[<xref rid="REF26" ref-type="bibr">26</xref>]&#x000a0;received a &#x0201c;low&#x0201d; risk. For reporting, Paikkatt et al.&#x000a0;[<xref rid="REF23" ref-type="bibr">23</xref>]&#x000a0;and Karg&#x000fc;l et al.&#x000a0;[<xref rid="REF22" ref-type="bibr">22</xref>]&#x000a0;presented &#x0201c;high&#x0201d; risk, whereas others like Gholami et al.&#x000a0;[<xref rid="REF21" ref-type="bibr">21</xref>]&#x000a0;and Qamar et al.&#x000a0;[<xref rid="REF24" ref-type="bibr">24</xref>]&#x000a0;showed &#x0201c;low&#x0201d; risk. Most studies had &#x0201c;some concerns&#x0201d; in intermediate domains such as D2 (materials and methods) and D4 (experimental controls), indicating a moderate risk of bias in methodological robustness&#x000a0;[<xref rid="REF17" ref-type="bibr">17</xref>-<xref rid="REF27" ref-type="bibr">27</xref>].</p><fig position="anchor" fig-type="figure" id="FIG2"><label>Figure 2</label><caption><title>Bias assessment using the RoB 2.0 tool</title><p>Image credits: The authors of this article.</p></caption><graphic xlink:href="cureus-0017-00000082876-i02" position="float"/></fig><p>The QUIN tool provided further insights for specific domains (Figure&#x000a0;<xref rid="FIG3" ref-type="fig">3</xref>). Under the &#x0201c;materials and methods&#x0201d; domain, there were &#x0201c;high&#x0201d; quality studies such as Wassel et al.&#x000a0;[<xref rid="REF27" ref-type="bibr">27</xref>], whereas Chandra and Thosar&#x000a0;[<xref rid="REF18" ref-type="bibr">18</xref>]&#x000a0;and Reddy et al.&#x000a0;[<xref rid="REF25" ref-type="bibr">25</xref>]&#x000a0;appeared to be of &#x0201c;moderate&#x0201d; quality. Quality of data was again a persisting problem: both Chandra and Thosar&#x000a0;[<xref rid="REF18" ref-type="bibr">18</xref>]&#x000a0;and Reddy et al.&#x000a0;[<xref rid="REF25" ref-type="bibr">25</xref>]&#x000a0;were rated &#x0201c;low&#x0201d; in this domain. According to Wassel et al.&#x000a0;[<xref rid="REF27" ref-type="bibr">27</xref>], rated &#x0201c;low,&#x0201d; experimental controls were not uniformly applied compared to Chandra and Thosar&#x000a0;[<xref rid="REF18" ref-type="bibr">18</xref>], rated &#x0201c;high.&#x0201d; The reporting quality was high in both Wassel et al.&#x000a0;[<xref rid="REF27" ref-type="bibr">27</xref>]&#x000a0;and Reddy et al.&#x000a0;[<xref rid="REF25" ref-type="bibr">25</xref>], suggesting thorough documentation, whereas Chandra and Thosar&#x000a0;[<xref rid="REF18" ref-type="bibr">18</xref>]&#x000a0;was rated &#x0201c;moderate.&#x0201d;</p><fig position="anchor" fig-type="figure" id="FIG3"><label>Figure 3</label><caption><title>Bias assessment using the QUIN tool</title><p>Image credits: The authors of this article.</p></caption><graphic xlink:href="cureus-0017-00000082876-i03" position="float"/></fig><p>Discussion</p><p>Dental caries is one of the most common oral infections in children. Not infrequently, it necessitates the removal of most of the structure of the tooth involved due to traditional forms of restorative procedures. Inevitably, this leads to exposure of the pulp or the importance of more invasive restorations. Lesion sterilization and tissue repair (LSTR) is an approach that attempts to directly address infection within the dental caries lesion by promoting natural repair and minimizing invasive restoration procedures&#x000a0;[<xref rid="REF19" ref-type="bibr">19</xref>]. In pediatric patients, the underdevelopment of pain-responsive nerve fibers often delays early diagnosis, and cases present with severe pain that requires invasive interventions such as extractions or pulpectomies&#x000a0;[<xref rid="REF27" ref-type="bibr">27</xref>].</p><p>TAP, a constituent of LSTR, is metronidazole, ciprofloxacin, and minocycline, typically in a 1:1:1 ratio. The combination has been modified by substituting minocycline with clindamycin or other appropriate antibiotics, depending on availability and patient-specific requirements. The minimally invasive nature of LSTR avoids extensive instrumentation, which significantly reduces treatment time and enhances patient cooperation, especially in children&#x000a0;[<xref rid="REF28" ref-type="bibr">28</xref>,<xref rid="REF29" ref-type="bibr">29</xref>].</p><p>Ahirwar et al.&#x000a0;[<xref rid="REF17" ref-type="bibr">17</xref>]&#x000a0;explored herbal alternatives, finding O. sanctum less effective than TAP but indicating its potential for biocompatibility. This result was much lower than those of Dutta et al.&#x000a0;[<xref rid="REF19" ref-type="bibr">19</xref>]&#x000a0;and Qamar et al.&#x000a0;[<xref rid="REF24" ref-type="bibr">24</xref>], which claimed that the effectiveness of TAP plus CHX was much better than that of resistant bacteria. Similar results were observed in Chandra and Thosar&#x000a0;[<xref rid="REF18" ref-type="bibr">18</xref>], in which the 3C antibiotic paste showed greater effectiveness than TAP, partly matching with Gholami et al.&#x000a0;[<xref rid="REF21" ref-type="bibr">21</xref>], where TAP proved better than nano-CH.</p><p>Ghahramani et al.&#x000a0;[<xref rid="REF20" ref-type="bibr">20</xref>]&#x000a0;highlighted TAP&#x02019;s efficiency on resistant bacterial species, consistent with Dutta et al.&#x000a0;[<xref rid="REF19" ref-type="bibr">19</xref>]&#x000a0;and Qamar et al.&#x000a0;[<xref rid="REF24" ref-type="bibr">24</xref>]; however, in contrast with Paikkatt et al.&#x000a0;[<xref rid="REF23" ref-type="bibr">23</xref>], who observed Ca(OH)&#x02082; and metronidazole formulations as inappropriate for total microbiological elimination.</p><p>Verma et al.&#x000a0;[<xref rid="REF26" ref-type="bibr">26</xref>]&#x000a0;demonstrated that Pulpotec outperformed clindamycin-modified TAP in radiographic outcomes, showing partial dissimilarity with studies emphasizing TAP&#x02019;s efficacy. Reddy et al.&#x000a0;[<xref rid="REF25" ref-type="bibr">25</xref>]&#x000a0;and Wassel et al.&#x000a0;[<xref rid="REF27" ref-type="bibr">27</xref>]&#x000a0;evaluated long-term and nanoparticle-based formulations, respectively, with both highlighting the sustained success of TAP and CS-CHX nanoparticles. These results were in accordance with Qamar et al.&#x000a0;[<xref rid="REF24" ref-type="bibr">24</xref>]&#x000a0;and Dutta et al.&#x000a0;[<xref rid="REF19" ref-type="bibr">19</xref>], who had considered the improved antimicrobial activity of TAP-based modifications, though Wassel et al.&#x000a0;[<xref rid="REF27" ref-type="bibr">27</xref>]&#x000a0;were the only ones who highlighted extended residual effects.</p><p>This technique preserves healthy tooth structures, reduces discomfort, and emphasizes infection elimination and tissue regeneration. LSTR has been refined through various combinations of antibiotics, with ongoing research exploring optimal formulations&#x000a0;[<xref rid="REF30" ref-type="bibr">30</xref>,<xref rid="REF31" ref-type="bibr">31</xref>]. Evidence supports its ability to improve outcomes in primary teeth by reducing bacterial infections and promoting tissue healing. For instance, clindamycin-based TAP formulations have shown better results than minocycline-based alternatives in certain trials&#x000a0;[<xref rid="REF30" ref-type="bibr">30</xref>,<xref rid="REF32" ref-type="bibr">32</xref>-<xref rid="REF34" ref-type="bibr">34</xref>].</p><p>Both our review and the study by Malu and Khubchandani&#x000a0;[<xref rid="REF1" ref-type="bibr">1</xref>]&#x000a0;have emphasized the need for proper intracanal medicaments to overcome the anatomical challenges of root canals and the broad-spectrum antimicrobial efficacy of TAP. Their evaluation, like our findings, has reaffirmed the role of TAP in effective microbial reduction and infection control, especially in challenging cases.</p><p>Achanta et al.&#x000a0;[<xref rid="REF35" ref-type="bibr">35</xref>]&#x000a0;highlighted the role of LSTR as a minimally invasive alternative to traditional pulpectomy, similar to our review, which emphasizes TAP and its variations that avoid extensive instrumentation and promote tissue repair. Both studies emphasized the preservation of vital pulp tissues and improved patient cooperation in pediatric endodontics.</p><p>Garrocho-Rangel et al.&#x000a0;[<xref rid="REF36" ref-type="bibr">36</xref>]&#x000a0;reported high clinical and radiographic success for CTZ paste, similar to the results of TAP-based formulations in our review. Both reviews showed adequate antimicrobial activity and clinical efficacy in the treatment of pulpally involved primary molars, but with differences in the formulations. Agarwal et al.&#x000a0;[<xref rid="REF37" ref-type="bibr">37</xref>]&#x000a0;have reported that LSTR had excellent clinical and radiographic success, comparable to that seen in TAP and nanoparticle-based formulations in our review, which underlined the efficacy of LSTR for the management of infected primary teeth.</p><p>Malu and Khubchandani&#x000a0;[<xref rid="REF1" ref-type="bibr">1</xref>]&#x000a0;focused on the scope of TAP for pulp vitality maintenance, whereas our review was focused on broader issues, including modification in TAP, such as combination with CHX, clindamycin-based formulations, and advanced medicaments based on nanoparticles that provided higher efficiency and longer antimicrobial periods.</p><p>Achanta et al.&#x000a0;[<xref rid="REF35" ref-type="bibr">35</xref>]&#x000a0;highlighted that LSTR minimized patient pain and made the process of treatment easy; however, this is contrary to our findings, in which some TAP formulations show adverse effects like root resorption. More than that, our systematic review covered more aspects of modifications of TAP formulations and comparative effectiveness, which were not emphasized by Achanta et al.&#x000a0;[<xref rid="REF35" ref-type="bibr">35</xref>]</p><p>Garrocho-Rangel et al.&#x000a0;[<xref rid="REF36" ref-type="bibr">36</xref>]&#x000a0;reported no significant differences between the clinical, radiographic, and antimicrobial outcomes of CTZ paste and conventional pulpectomy, whereas our review found TAP and its modifications to consistently be superior to the traditional techniques like pulpectomy. Furthermore, biocompatibility concerns of the CTZ paste were reported in their findings, which were less emphasized in our review of TAP formulations.</p><p>Agarwal et al.&#x000a0;[<xref rid="REF37" ref-type="bibr">37</xref>]&#x000a0;found no statistically significant difference in the success of Vitapex and LSTR. Our review showed that TAP-based therapies surpassed other medicaments for treatment, such as calcium hydroxide and metronidazole formulations.&#x000a0;</p><p>Limitations</p><p>This review was not without its weaknesses: variability in study designs, small sample sizes, and inconsistent reporting of radiographic outcomes. Protocols for reporting clinical and microbial outcomes were largely standardized, though not uniformly reported. Long-term effects and the possibility of adverse outcomes of new formulations have not yet been explored.</p></sec><sec sec-type="conclusions"><title>Conclusions</title><p>As a whole, the included studies reveal important information regarding the treatment of infections in primary teeth with tailored intracanal medications. TAP, when either combined with CHX or used as nanoparticles, was always shown to be superior to other antibacterial activities. Novel formulations such as 3C paste and CS-CHX nanoparticles also showed promising results, although they were limited by resistance and discoloration; further clinical validations are required in these areas. In terms of biocompatibility, calcium hydroxide and the less successful herbal alternatives were still useful. The findings emphasize the need for continuous innovation and strict evaluation of intracanal medications to improve therapeutic success and reduce side effects in pediatric endodontics.</p></sec></body><back><fn-group content-type="conflict"><title>Disclosures</title><fn fn-type="COI-statement"><p><bold>Conflicts of interest:</bold> In compliance with the ICMJE uniform disclosure form, all authors declare the following:</p><p><bold>Payment/services info:</bold> All authors have declared that no financial support was received from any organization for the submitted work.</p><p><bold>Financial relationships:</bold> All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work.</p><p><bold>Other relationships:</bold> All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.</p></fn></fn-group><fn-group content-type="other"><title>Author Contributions</title><fn fn-type="other"><p><bold>Concept and design:</bold>&#x000a0; Archita Barve, Laxmi Lakade, Preetam Shah, Shweta Chaudhary, Shweta Jajoo, Gandhali Joshi</p><p><bold>Acquisition, analysis, or interpretation of data:</bold>&#x000a0; Archita Barve, Laxmi Lakade, Preetam Shah, Shweta Chaudhary, Shweta Jajoo, Gandhali Joshi</p><p><bold>Drafting of the manuscript:</bold>&#x000a0; Archita Barve, Laxmi Lakade, Preetam Shah, Shweta Chaudhary, Shweta Jajoo, Gandhali Joshi</p><p><bold>Critical review of the manuscript for important intellectual content:</bold>&#x000a0; Archita Barve, Laxmi Lakade, Preetam Shah, Shweta Chaudhary, Shweta Jajoo, Gandhali Joshi</p><p><bold>Supervision:</bold>&#x000a0; Archita Barve</p></fn></fn-group><ref-list><title>References</title><ref id="REF1"><label>1</label><element-citation publication-type="journal"><article-title>Triple antibiotic paste: a suitable medicament for intracanal disinfection</article-title><source>Cureus</source><person-group>
<name><surname>Malu</surname><given-names>K</given-names></name>
<name><surname>Khubchandani</surname><given-names>M</given-names></name>
</person-group><fpage>0</fpage><volume>14</volume><year>2022</year></element-citation></ref><ref id="REF2"><label>2</label><element-citation publication-type="journal"><article-title>Comparison of modified triple antibiotic paste in two concentrations for lesion sterilization and tissue repair in primary molars: an in vivo interventional randomized clinical trial</article-title><source>Int J Clin Pediatr Dent</source><person-group>
<name><surname>Shankar</surname><given-names>K</given-names></name>
<name><surname>Ramkumar</surname><given-names>H</given-names></name>
<name><surname>Dhakshinamoorthy</surname><given-names>S</given-names></name>
<name><surname>Paulindraraj</surname><given-names>S</given-names></name>
<name><surname>Jayakaran</surname><given-names>TG</given-names></name>
<name><surname>Bommareddy</surname><given-names>CS</given-names></name>
</person-group><fpage>388</fpage><lpage>392</lpage><volume>14</volume><year>2021</year><pub-id pub-id-type="pmid">34720512</pub-id>
</element-citation></ref><ref id="REF3"><label>3</label><element-citation publication-type="journal"><article-title>Infection control in teeth with apical periodontitis using a triple antibiotic solution or calcium hydroxide with chlorhexidine: a randomized clinical trial</article-title><source>J Endod</source><person-group>
<name><surname>Arruda</surname><given-names>ME</given-names></name>
<name><surname>Neves</surname><given-names>MA</given-names></name>
<name><surname>Diogenes</surname><given-names>A</given-names></name>
<name><surname>Mdala</surname><given-names>I</given-names></name>
<name><surname>Guilherme</surname><given-names>BP</given-names></name>
<name><surname>Siqueira JF</surname><given-names>Jr</given-names></name>
<name><surname>R&#x000f4;&#x000e7;as</surname><given-names>IN</given-names></name>
</person-group><fpage>1474</fpage><lpage>1479</lpage><volume>44</volume><year>2018</year><pub-id pub-id-type="pmid">30144986</pub-id>
</element-citation></ref><ref id="REF4"><label>4</label><element-citation publication-type="journal"><article-title>Endodontic treatment of primary molars with antibiotic paste: a report of 38 cases</article-title><source>J Clin Pediatr Dent</source><person-group>
<name><surname>de Deus Moura Lde</surname><given-names>F</given-names></name>
<name><surname>de Lima Mde</surname><given-names>D</given-names></name>
<name><surname>Lima</surname><given-names>CC</given-names></name>
<name><surname>Machado</surname><given-names>JI</given-names></name>
<name><surname>de Moura</surname><given-names>MS</given-names></name>
<name><surname>de Carvalho</surname><given-names>PV</given-names></name>
</person-group><fpage>175</fpage><lpage>177</lpage><volume>40</volume><year>2016</year><uri xlink:href="https://pubmed.ncbi.nlm.nih.gov/27472562/">https://pubmed.ncbi.nlm.nih.gov/27472562/</uri><pub-id pub-id-type="pmid">27472562</pub-id>
</element-citation></ref><ref id="REF5"><label>5</label><element-citation publication-type="journal"><article-title>Microbial evaluation of traumatized teeth treated with triple antibiotic paste or calcium hydroxide with 2% chlorhexidine gel in pulp revascularization</article-title><source>J Endod</source><person-group>
<name><surname>Nagata</surname><given-names>JY</given-names></name>
<name><surname>Soares</surname><given-names>AJ</given-names></name>
<name><surname>Souza-Filho</surname><given-names>FJ</given-names></name>
<name><surname>Zaia</surname><given-names>AA</given-names></name>
<name><surname>Ferraz</surname><given-names>CC</given-names></name>
<name><surname>Almeida</surname><given-names>JF</given-names></name>
<name><surname>Gomes</surname><given-names>BP</given-names></name>
</person-group><fpage>778</fpage><lpage>783</lpage><volume>40</volume><year>2014</year><pub-id pub-id-type="pmid">24862703</pub-id>
</element-citation></ref><ref id="REF6"><label>6</label><element-citation publication-type="journal"><article-title>Comparison of the antibacterial effect of modified 3-mix paste versus Ultrapex over anaerobic microorganisms from infected root canals of primary teeth: an in vitro study</article-title><source>J Clin Pediatr Dent</source><person-group>
<name><surname>Velasco-Loera</surname><given-names>N</given-names></name>
<name><surname>De Alba-Vazquez</surname><given-names>Y</given-names></name>
<name><surname>Garrocho-Rangel</surname><given-names>A</given-names></name>
<name><surname>Gonzalez-Amaro</surname><given-names>AM</given-names></name>
<name><surname>Flores-Reyes</surname><given-names>H</given-names></name>
<name><surname>Pozos-Guillen</surname><given-names>AJ</given-names></name>
</person-group><fpage>239</fpage><lpage>244</lpage><volume>36</volume><year>2012</year><uri xlink:href="https://pubmed.ncbi.nlm.nih.gov/22838224/">https://pubmed.ncbi.nlm.nih.gov/22838224/</uri><pub-id pub-id-type="pmid">22838224</pub-id>
</element-citation></ref><ref id="REF7"><label>7</label><element-citation publication-type="journal"><article-title>Comparative evaluation of antimicrobial efficacy of triple antibiotic paste and amoxicillin clavulanate paste as an intracanal medicament against Enterococcus faecalis: an in vitro study</article-title><source>Dent Res J (Isfahan)</source><person-group>
<name><surname>Sasikala</surname><given-names>D</given-names></name>
<name><surname>Baghkomeh</surname><given-names>PN</given-names></name>
<name><surname>Farzan</surname><given-names>JM</given-names></name>
</person-group><fpage>10</fpage><volume>21</volume><year>2024</year><uri xlink:href="https://pubmed.ncbi.nlm.nih.gov/38476718/">https://pubmed.ncbi.nlm.nih.gov/38476718/</uri><pub-id pub-id-type="pmid">38476718</pub-id>
</element-citation></ref><ref id="REF8"><label>8</label><element-citation publication-type="journal"><article-title>Persistent, recurrent, and acquired infection of the root canal system post&#x02010;treatment</article-title><source>Endod Topics</source><person-group>
<name><surname>Haapasalo</surname><given-names>M</given-names></name>
<name><surname>Udn&#x000e6;s</surname><given-names>T</given-names></name>
<name><surname>Endal</surname><given-names>U</given-names></name>
</person-group><fpage>29</fpage><lpage>56</lpage><volume>6</volume><year>2003</year><uri xlink:href="https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1601-1546.2003.00041.x">https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1601-1546.2003.00041.x</uri></element-citation></ref><ref id="REF9"><label>9</label><element-citation publication-type="journal"><article-title>Evaluation of paste containing gentamicin, amoxicillin and metronidazole in endodontic treatment of primary molars in vivo</article-title><source>Chin J Dent Res</source><person-group>
<name><surname>Parakh</surname><given-names>K</given-names></name>
<name><surname>Shetty</surname><given-names>RM</given-names></name>
</person-group><fpage>57</fpage><lpage>64</lpage><volume>22</volume><year>2019</year><pub-id pub-id-type="pmid">30746534</pub-id>
</element-citation></ref><ref id="REF10"><label>10</label><element-citation publication-type="journal"><article-title>The use of calcium hydroxide, antibiotics and biocides as antimicrobial medicaments in endodontics</article-title><source>Aust Dent J</source><person-group>
<name><surname>Athanassiadis</surname><given-names>B</given-names></name>
<name><surname>Abbott</surname><given-names>PV</given-names></name>
<name><surname>Walsh</surname><given-names>LJ</given-names></name>
</person-group><fpage>0</fpage><lpage>82</lpage><volume>52</volume><year>2007</year></element-citation></ref><ref id="REF11"><label>11</label><element-citation publication-type="journal"><article-title>Comparative evaluation of clinical and radiographic success of three different lesion sterilization and tissue repair techniques as treatment options in primary molars requiring pulpectomy: an in vivo study</article-title><source>J Indian Soc Pedod Prev Dent</source><person-group>
<name><surname>Lokade</surname><given-names>A</given-names></name>
<name><surname>Thakur</surname><given-names>S</given-names></name>
<name><surname>Singhal</surname><given-names>P</given-names></name>
<name><surname>Chauhan</surname><given-names>D</given-names></name>
<name><surname>Jayam</surname><given-names>C</given-names></name>
</person-group><fpage>185</fpage><lpage>191</lpage><volume>37</volume><year>2019</year><pub-id pub-id-type="pmid">31249184</pub-id>
</element-citation></ref><ref id="REF12"><label>12</label><element-citation publication-type="journal"><article-title>Endodontic treatment of necrosed primary teeth using two different combinations of antibacterial drugs: an in vivo study</article-title><source>J Indian Soc Pedod Prev Dent</source><person-group>
<name><surname>Pinky</surname><given-names>C</given-names></name>
<name><surname>Shashibhushan</surname><given-names>KK</given-names></name>
<name><surname>Subbareddy</surname><given-names>VV</given-names></name>
</person-group><fpage>121</fpage><lpage>127</lpage><volume>29</volume><year>2011</year><pub-id pub-id-type="pmid">21911950</pub-id>
</element-citation></ref><ref id="REF13"><label>13</label><element-citation publication-type="journal"><article-title>PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews</article-title><source>BMJ</source><person-group>
<name><surname>Page</surname><given-names>MJ</given-names></name>
<name><surname>Moher</surname><given-names>D</given-names></name>
<name><surname>Bossuyt</surname><given-names>PM</given-names></name>
<etal/>
</person-group><fpage>0</fpage><volume>372</volume><year>2021</year></element-citation></ref><ref id="REF14"><label>14</label><element-citation publication-type="journal"><article-title>Cochrane's risk of bias tool for non-randomized studies (ROBINS-I) is frequently misapplied: a methodological systematic review</article-title><source>J Clin Epidemiol</source><person-group>
<name><surname>Igelstr&#x000f6;m</surname><given-names>E</given-names></name>
<name><surname>Campbell</surname><given-names>M</given-names></name>
<name><surname>Craig</surname><given-names>P</given-names></name>
<name><surname>Katikireddi</surname><given-names>SV</given-names></name>
</person-group><fpage>22</fpage><lpage>32</lpage><volume>140</volume><year>2021</year><pub-id pub-id-type="pmid">34437948</pub-id>
</element-citation></ref><ref id="REF15"><label>15</label><element-citation publication-type="journal"><article-title>RoB 2: a revised tool for assessing risk of bias in randomised trials</article-title><source>BMJ</source><person-group>
<name><surname>Sterne</surname><given-names>JA</given-names></name>
<name><surname>Savovi&#x00107;</surname><given-names>J</given-names></name>
<name><surname>Page</surname><given-names>MJ</given-names></name>
<etal/>
</person-group><fpage>0</fpage><volume>366</volume><year>2019</year></element-citation></ref><ref id="REF16"><label>16</label><element-citation publication-type="journal"><article-title>Development and validation of a risk-of-bias tool for assessing in&#x000a0;vitro studies conducted in dentistry: the QUIN</article-title><source>J Prosthet Dent</source><person-group>
<name><surname>Sheth</surname><given-names>VH</given-names></name>
<name><surname>Shah</surname><given-names>NP</given-names></name>
<name><surname>Jain</surname><given-names>R</given-names></name>
<name><surname>Bhanushali</surname><given-names>N</given-names></name>
<name><surname>Bhatnagar</surname><given-names>V</given-names></name>
</person-group><fpage>1038</fpage><lpage>1042</lpage><volume>131</volume><year>2024</year><uri xlink:href="https://pubmed.ncbi.nlm.nih.gov/35752496/">https://pubmed.ncbi.nlm.nih.gov/35752496/</uri><pub-id pub-id-type="pmid">35752496</pub-id>
</element-citation></ref><ref id="REF17"><label>17</label><element-citation publication-type="journal"><article-title>A clinical trial comparing antimicrobial efficacy of "essential oil of Ocimum sanctum" with triple antibiotic paste as an intracanal medicament in primary molars</article-title><source>J Indian Soc Pedod Prev Dent</source><person-group>
<name><surname>Ahirwar</surname><given-names>P</given-names></name>
<name><surname>Shashikiran</surname><given-names>ND</given-names></name>
<name><surname>Sundarraj</surname><given-names>RK</given-names></name>
<name><surname>Singhla</surname><given-names>S</given-names></name>
<name><surname>Thakur</surname><given-names>RA</given-names></name>
<name><surname>Maran</surname><given-names>S</given-names></name>
</person-group><fpage>191</fpage><lpage>197</lpage><volume>36</volume><year>2018</year><pub-id pub-id-type="pmid">29970638</pub-id>
</element-citation></ref><ref id="REF18"><label>18</label><element-citation publication-type="journal"><article-title>Comparative evaluation of antimicrobial efficacy of 3C antibiotic paste with triple antibiotic paste as root canal filling material for primary teeth: an in-vitro study</article-title><source>F1000Res</source><person-group>
<name><surname>Chandra</surname><given-names>A</given-names></name>
<name><surname>Thosar</surname><given-names>N</given-names></name>
</person-group><fpage>754</fpage><volume>12</volume><year>2023</year><pub-id pub-id-type="pmid">40176787</pub-id>
</element-citation></ref><ref id="REF19"><label>19</label><element-citation publication-type="journal"><article-title>Evaluation of antimicrobial efficacy of various intracanal medicaments in primary teeth: an in vivo study</article-title><source>Int J Clin Pediatr Dent</source><person-group>
<name><surname>Dutta</surname><given-names>B</given-names></name>
<name><surname>S Dhull</surname><given-names>K</given-names></name>
<name><surname>Das</surname><given-names>D</given-names></name>
<name><surname>Samir</surname><given-names>PV</given-names></name>
<name><surname>K Verma</surname><given-names>R</given-names></name>
<name><surname>Singh</surname><given-names>N</given-names></name>
</person-group><fpage>267</fpage><lpage>271</lpage><volume>10</volume><year>2017</year><pub-id pub-id-type="pmid">29104387</pub-id>
</element-citation></ref><ref id="REF20"><label>20</label><element-citation publication-type="journal"><article-title>Antimicrobial efficacy of intracanal medicaments against E. Faecalis bacteria in infected primary molars by using real-time PCR: a randomized clinical trial</article-title><source>Int J Dent</source><person-group>
<name><surname>Ghahramani</surname><given-names>Y</given-names></name>
<name><surname>Mohammadi</surname><given-names>N</given-names></name>
<name><surname>Gholami</surname><given-names>A</given-names></name>
<name><surname>Ghaffaripour</surname><given-names>D</given-names></name>
</person-group><fpage>6669607</fpage><volume>2020</volume><year>2020</year><pub-id pub-id-type="pmid">33414827</pub-id>
</element-citation></ref><ref id="REF21"><label>21</label><element-citation publication-type="journal"><article-title>Triple antibiotic paste versus nano calcium hydroxide as an intracanal medicament in human primary molars: a randomized clinical trial</article-title><source>G Ital Endod</source><person-group>
<name><surname>Gholami</surname><given-names>A</given-names></name>
<name><surname>Asadi</surname><given-names>K</given-names></name>
<name><surname>Samiraninezhad</surname><given-names>N</given-names></name>
<name><surname>Ghaffaripour</surname><given-names>D</given-names></name>
<name><surname>Safari</surname><given-names>A</given-names></name>
<name><surname>Ghahramani</surname><given-names>Y</given-names></name>
<name><surname>Abbaszadegan</surname><given-names>A</given-names></name>
</person-group><fpage>1</fpage><lpage>10</lpage><volume>37</volume><year>2023</year><uri xlink:href="https://www.giornaleitalianoendodonzia.it/gie/article/view/411">https://www.giornaleitalianoendodonzia.it/gie/article/view/411</uri></element-citation></ref><ref id="REF22"><label>22</label><element-citation publication-type="journal"><article-title>Conventional endodontic treatment of primary molars using metronidazole as an intra-canal medicament: a pilot study</article-title><source>Eur Arch Paediatr Dent</source><person-group>
<name><surname>Karg&#x000fc;l</surname><given-names>B</given-names></name>
<name><surname>Tanboga</surname><given-names>I</given-names></name>
<name><surname>Altinok</surname><given-names>B</given-names></name>
</person-group><fpage>196</fpage><lpage>200</lpage><volume>11</volume><year>2010</year><uri xlink:href="https://doi.org/10.1007/BF03262744">https://doi.org/10.1007/BF03262744</uri><pub-id pub-id-type="pmid">20840831</pub-id>
</element-citation></ref><ref id="REF23"><label>23</label><element-citation publication-type="journal"><article-title>Efficacy of various intracanal medicaments against aerobic and facultative anaerobic microorganism found in human primary teeth with necrotic pulp: a randomized clinical trial</article-title><source>J Indian Soc Pedod Prev Dent</source><person-group>
<name><surname>Paikkatt</surname><given-names>JV</given-names></name>
<name><surname>Aslam</surname><given-names>S</given-names></name>
<name><surname>Sreedharan</surname><given-names>S</given-names></name>
<name><surname>Philomina</surname><given-names>B</given-names></name>
<name><surname>Kannan</surname><given-names>VP</given-names></name>
<name><surname>Madhu</surname><given-names>S</given-names></name>
</person-group><fpage>268</fpage><lpage>272</lpage><volume>36</volume><year>2018</year><pub-id pub-id-type="pmid">30246748</pub-id>
</element-citation></ref><ref id="REF24"><label>24</label><element-citation publication-type="journal"><article-title>Comparative evaluation of antimicrobial efficacy of calcium hydroxide, chlorhexidine, and triple antibiotic paste in different combination forms as intracanal medicaments against Enterococcus faecalis in primary teeth: an in vivo randomized clinical trial</article-title><source>Int J Clin Pediatr Dent</source><person-group>
<name><surname>Qamar</surname><given-names>S</given-names></name>
<name><surname>Jayanna</surname><given-names>R</given-names></name>
<name><surname>Ahuja</surname><given-names>VR</given-names></name>
</person-group><fpage>448</fpage><lpage>452</lpage><volume>16</volume><year>2023</year><pub-id pub-id-type="pmid">37496940</pub-id>
</element-citation></ref><ref id="REF25"><label>25</label><element-citation publication-type="journal"><article-title>Endodontic treatment of chronically infected primary teeth using triple antibiotic paste: an in vivo study</article-title><source>J Conserv Dent</source><person-group>
<name><surname>Reddy</surname><given-names>GA</given-names></name>
<name><surname>Sridevi</surname><given-names>E</given-names></name>
<name><surname>Sai Sankar</surname><given-names>AJ</given-names></name>
<name><surname>Pranitha</surname><given-names>K</given-names></name>
<name><surname>Pratap Gowd</surname><given-names>MJ</given-names></name>
<name><surname>Vinay</surname><given-names>C</given-names></name>
</person-group><fpage>405</fpage><lpage>410</lpage><volume>20</volume><year>2017</year><uri xlink:href="https://pubmed.ncbi.nlm.nih.gov/29430091/">https://pubmed.ncbi.nlm.nih.gov/29430091/</uri><pub-id pub-id-type="pmid">29430091</pub-id>
</element-citation></ref><ref id="REF26"><label>26</label><element-citation publication-type="journal"><article-title>Is clindamycin-modified triple antibiotic paste better than iodoform-based medicament for the treatment of non-vital primary molars using LSTR technique - a randomised clinical trial</article-title><source>Indian J Physiol Pharmacol</source><person-group>
<name><surname>Verma</surname><given-names>N</given-names></name>
<name><surname>Gupta</surname><given-names>A</given-names></name>
<name><surname>Garg</surname><given-names>S</given-names></name>
<name><surname>Arya</surname><given-names>V</given-names></name>
<name><surname>Dogra</surname><given-names>S</given-names></name>
<name><surname>Dhankar</surname><given-names>M</given-names></name>
</person-group><fpage>276</fpage><lpage>285</lpage><volume>66</volume><year>2022</year><uri xlink:href="https://ijpp.com/is-clindamycin-modified-triple-antibiotic-paste-better-than-iodoform-based-medicament-for-the-treatment-of-non-vital-primary-molars-using-lstr-technique-a-randomised-clinical-trial/">https://ijpp.com/is-clindamycin-modified-triple-antibiotic-paste-better-than-iodoform-based-medicament-for-the-treatment-of-non-vital-primary-molars-using-lstr-technique-a-randomised-clinical-trial/</uri></element-citation></ref><ref id="REF27"><label>27</label><element-citation publication-type="journal"><article-title>Direct and residual antimicrobial effect of 2% chlorhexidine gel, double antibiotic paste and chitosan- chlorhexidine nanoparticles as intracanal medicaments against Enterococcus faecalis and Candida albicans in primary molars: an in-vitro study</article-title><source>BMC Oral Health</source><person-group>
<name><surname>Wassel</surname><given-names>M</given-names></name>
<name><surname>Radwan</surname><given-names>M</given-names></name>
<name><surname>Elghazawy</surname><given-names>R</given-names></name>
</person-group><fpage>296</fpage><volume>23</volume><year>2023</year><pub-id pub-id-type="pmid">37542254</pub-id>
</element-citation></ref><ref id="REF28"><label>28</label><element-citation publication-type="journal"><article-title>The effect of an antibacterial mixture and non-instrumentation endodontic treatment in primary teeth: a systematic review and meta-analyses</article-title><source>Saudi Dent J</source><person-group>
<name><surname>Alrayes</surname><given-names>N</given-names></name>
<name><surname>Almaimouni</surname><given-names>Y</given-names></name>
<name><surname>Tounsi</surname><given-names>A</given-names></name>
<name><surname>Tarabzouni</surname><given-names>K</given-names></name>
<name><surname>Alonaizan</surname><given-names>F</given-names></name>
<name><surname>Salem Ibrahim</surname><given-names>M</given-names></name>
</person-group><fpage>575</fpage><lpage>588</lpage><volume>35</volume><year>2023</year><pub-id pub-id-type="pmid">37823084</pub-id>
</element-citation></ref><ref id="REF29"><label>29</label><element-citation publication-type="journal"><article-title>Revascularization of immature permanent teeth with apical periodontitis: new treatment protocol?</article-title><source>J Endod</source><person-group>
<name><surname>Banchs</surname><given-names>F</given-names></name>
<name><surname>Trope</surname><given-names>M</given-names></name>
</person-group><fpage>196</fpage><lpage>200</lpage><volume>30</volume><year>2004</year><pub-id pub-id-type="pmid">15085044</pub-id>
</element-citation></ref><ref id="REF30"><label>30</label><element-citation publication-type="journal"><article-title>Tooth discoloration induced by endodontic materials: a laboratory study</article-title><source>Int Endod J</source><person-group>
<name><surname>Lenherr</surname><given-names>P</given-names></name>
<name><surname>Allgayer</surname><given-names>N</given-names></name>
<name><surname>Weiger</surname><given-names>R</given-names></name>
<name><surname>Filippi</surname><given-names>A</given-names></name>
<name><surname>Attin</surname><given-names>T</given-names></name>
<name><surname>Krastl</surname><given-names>G</given-names></name>
</person-group><fpage>942</fpage><lpage>949</lpage><volume>45</volume><year>2012</year><pub-id pub-id-type="pmid">22506849</pub-id>
</element-citation></ref><ref id="REF31"><label>31</label><element-citation publication-type="journal"><article-title>Lesion sterilization and tissue repair in primary teeth</article-title><source>SRM J Res Dent Sci</source><person-group>
<name><surname>Shetty</surname><given-names>AA</given-names></name>
<name><surname>Geethanjali</surname><given-names>G</given-names></name>
<name><surname>Hegde</surname><given-names>AM</given-names></name>
</person-group><fpage>99</fpage><lpage>105</lpage><volume>11</volume><year>2020</year><uri xlink:href="https://journals.lww.com/srmj/fulltext/2020/11020/lesion_sterilization_and_tissue_repair_in_primary.9.aspx">https://journals.lww.com/srmj/fulltext/2020/11020/lesion_sterilization_and_tissue_repair_in_primary.9.aspx</uri></element-citation></ref><ref id="REF32"><label>32</label><element-citation publication-type="journal"><article-title>Endodontic treatment of primary teeth using combination of antibacterial drugs: an in vivo study</article-title><source>J Indian Soc Pedod Prev Dent</source><person-group>
<name><surname>Prabhakar</surname><given-names>AR</given-names></name>
<name><surname>Sridevi</surname><given-names>E</given-names></name>
<name><surname>Raju</surname><given-names>OS</given-names></name>
<name><surname>Satish</surname><given-names>V</given-names></name>
</person-group><fpage>0</fpage><lpage>10</lpage><volume>26 Suppl 1</volume><year>2008</year><uri xlink:href="https://pubmed.ncbi.nlm.nih.gov/18974537/">https://pubmed.ncbi.nlm.nih.gov/18974537/</uri></element-citation></ref><ref id="REF33"><label>33</label><element-citation publication-type="journal"><article-title>A comparative evaluation of non-instrumentation endodontic techniques with conventional ZOE pulpectomy in deciduous molars: an in vivo study</article-title><source>World J Dent</source><person-group>
<name><surname>Agarwal</surname><given-names>M</given-names></name>
<name><surname>Das</surname><given-names>UM</given-names></name>
<name><surname>Vishwanath</surname><given-names>D</given-names></name>
</person-group><fpage>187</fpage><lpage>192</lpage><volume>2</volume><year>2011</year><uri xlink:href="https://wjoud.com/doi/WJOUD/pdf/10.5005/jp-journals-10015-1081">https://wjoud.com/doi/WJOUD/pdf/10.5005/jp-journals-10015-1081</uri></element-citation></ref><ref id="REF34"><label>34</label><element-citation publication-type="journal"><article-title>Regenerative endodontics: a state of the art</article-title><source>Indian J Dent Res</source><person-group>
<name><surname>Bansal</surname><given-names>R</given-names></name>
<name><surname>Bansal</surname><given-names>R</given-names></name>
</person-group><fpage>122</fpage><lpage>131</lpage><volume>22</volume><year>2011</year><pub-id pub-id-type="pmid">21525690</pub-id>
</element-citation></ref><ref id="REF35"><label>35</label><element-citation publication-type="journal"><article-title>A comprehensive review of lesion sterilization and tissue repair: an alternative for pulpectomy in deciduous teeth</article-title><source>Cureus</source><person-group>
<name><surname>Achanta</surname><given-names>A</given-names></name>
<name><surname>Reche</surname><given-names>A</given-names></name>
<name><surname>Dakhale</surname><given-names>R</given-names></name>
<name><surname>Bharate</surname><given-names>RR</given-names></name>
</person-group><fpage>0</fpage><volume>15</volume><year>2023</year></element-citation></ref><ref id="REF36"><label>36</label><element-citation publication-type="journal"><article-title>Lesion sterilization tissue repair (LSTR) approach of non-vital primary molars with a chloramphenicol-tetracycline-ZOE antibiotic paste: a scoping review</article-title><source>J Clin Pediatr Dent</source><person-group>
<name><surname>Garrocho-Rangel</surname><given-names>A</given-names></name>
<name><surname>Jalomo-&#x000c1;vila</surname><given-names>C</given-names></name>
<name><surname>Rosales-Berber</surname><given-names>M&#x000c1;</given-names></name>
<name><surname>Pozos-Guill&#x000e9;n</surname><given-names>A</given-names></name>
</person-group><fpage>369</fpage><lpage>375</lpage><volume>45</volume><year>2021</year><uri xlink:href="https://pubmed.ncbi.nlm.nih.gov/34996109/">https://pubmed.ncbi.nlm.nih.gov/34996109/</uri><pub-id pub-id-type="pmid">34996109</pub-id>
</element-citation></ref><ref id="REF37"><label>37</label><element-citation publication-type="journal"><article-title>Evaluation of success rate of lesion sterilization and tissue repair compared to Vitapex in pulpally involved primary teeth: a systematic review</article-title><source>J Conserv Dent</source><person-group>
<name><surname>Agarwal</surname><given-names>SR</given-names></name>
<name><surname>Bendgude</surname><given-names>VD</given-names></name>
<name><surname>Kakodkar</surname><given-names>P</given-names></name>
</person-group><fpage>510</fpage><lpage>515</lpage><volume>22</volume><year>2019</year><uri xlink:href="https://pubmed.ncbi.nlm.nih.gov/33088056/">https://pubmed.ncbi.nlm.nih.gov/33088056/</uri><pub-id pub-id-type="pmid">33088056</pub-id>
</element-citation></ref></ref-list></back></article>